phosphorylated her2 tyr877 (Cell Signaling Technology Inc)
Cell Signaling Technology Inc is a verified supplier 
Cell Signaling Technology Inc manufactures this product 
94
Structured Review
Cell Signaling Technology Inc
phosphorylated her2 tyr877
Phosphorylated Her2 Tyr877, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 105 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phosphorylated+erbb2+tyr877/Phospho-HER2%2FErbB2+(Tyr877)+Antibody/pm40345509-63-10-41
Average 94 stars, based on 105 article reviews
Phosphorylated Her2 Tyr877, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 105 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/phosphorylated+erbb2+tyr877/Phospho-HER2%2FErbB2+(Tyr877)+Antibody/pm40345509-63-10-41
Average 94 stars, based on 105 article reviews
phosphorylated her2 tyr877 - by Bioz Stars,
2026-09
94/100 stars
Images
Related Articles
other:Article Title: Rac1 contributes to trastuzumab resistance of breast cancer cells: Rac1 as a potential therapeutic target for the treatment of trastuzumab-resistant breast cancer Article Snippet: Although treatment with trastuzumab improves outcomes forwomenwithErbB2-positivebreast cancer,manypatients who achieve an initial response to trastuzumab subsequently acquire resistance within 1 year.. Rac1, a Ras-like small GTPase, has been implicated in the control of cell growth andmorphology and is believed to be associatedwith breast cancer progression and metastasis.. Here, we show that when parental SKBR3 cells become resistant to trastuzumab, Rac1 activity is increased, leading to altered cell morphology, which is accompanied by significant cytoskeleton disorganization. Ubiquitin Proteomics:Article Title: Neuregulin-1 attenuated doxorubicin-induced decrease in cardiac troponins Article Snippet: LV proteins (50 μg) from controls ( n = 6), Dox ( n = 4), and Dox-NRG1-treated mice ( n = 4) and myocyte proteins (15 μg) from controls, Dox, and Dox-NRG1-treated NRVM ( n = 4 to 5 plates/group from at least 3 independent experiments) were separated by SDS page and transferred to Whatman nitrocellulose membrane (pore size, 0.2 μm; Fisher Scientific). .. Membranes were probed with antibodies against cardiac troponin I (GeneTex, San Antonio, TX), cardiac troponin T, cardiac troponin C, Tropomysin and α-sarcomeric actin, ubiquitin, COX IV and Tubulin (Abcam, Cambridge, MA), α-actinin (Sigma, St. Louis, MO), total erbB2 and erbB4 (Santa Cruz Biotechnology, Santa Cruz, CA), |